MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma
Abstract Sebaceous gland carcinoma (SGC) is a rare, but life-threatening condition with a predilection for the periocular region. Eyelid SGC can be broadly categorised into two subtypes, namely either nodular or pagetoid with the latter being more aggressive and requiring radical excision to save li...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8dbd7b7e4544abea6e78840cdc42587 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a8dbd7b7e4544abea6e78840cdc42587 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a8dbd7b7e4544abea6e78840cdc425872021-12-02T16:08:03ZMicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma10.1038/s41598-018-25900-z2045-2322https://doaj.org/article/a8dbd7b7e4544abea6e78840cdc425872018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25900-zhttps://doaj.org/toc/2045-2322Abstract Sebaceous gland carcinoma (SGC) is a rare, but life-threatening condition with a predilection for the periocular region. Eyelid SGC can be broadly categorised into two subtypes, namely either nodular or pagetoid with the latter being more aggressive and requiring radical excision to save life. We have identified key altered microRNAs (miRNA) involved in SGC shared by both subtypes, hsa-miR-34a-5p and hsa-miR-16-5p. However, their gene targets BCL2 and MYC were differentially expressed with both overexpressed in pagetoid but unchanged in nodular suggesting different modes of action of these two miRNAs on BCL/MYC expression. Hsa-miR-150p is nodular-specifically overexpressed, and its target ZEB1 was significantly downregulated in nodular SGC suggesting a tumour suppressor role. Invasive pagetoid subtype demonstrated specific overexpression of hsa-miR-205 and downregulation of hsa-miR-199a. Correspondingly, miRNA gene targets, EZH2 (by hsa-miR-205) and CD44 (by hsa-miR-199a), were both overexpressed in pagetoid SGC. CD44 has been identified as a potential cancer stem cell marker in head and neck squamous cell carcinoma and its overexpression in pagetoid cells represents a novel treatment target. Aberrant miRNAs and their gene targets have been identified in both SGC subtypes, paving the way for better molecular understanding of these tumours and identifying new treatment targets.John C. BladenJun WangAjanthah SangaralingamMariya MoosajeeCaroline FitchettClaude ChelalaMichele BeaconsfieldEdel A. O’TooleMichael P. PhilpottDaniel G. EzraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q John C. Bladen Jun Wang Ajanthah Sangaralingam Mariya Moosajee Caroline Fitchett Claude Chelala Michele Beaconsfield Edel A. O’Toole Michael P. Philpott Daniel G. Ezra MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma |
description |
Abstract Sebaceous gland carcinoma (SGC) is a rare, but life-threatening condition with a predilection for the periocular region. Eyelid SGC can be broadly categorised into two subtypes, namely either nodular or pagetoid with the latter being more aggressive and requiring radical excision to save life. We have identified key altered microRNAs (miRNA) involved in SGC shared by both subtypes, hsa-miR-34a-5p and hsa-miR-16-5p. However, their gene targets BCL2 and MYC were differentially expressed with both overexpressed in pagetoid but unchanged in nodular suggesting different modes of action of these two miRNAs on BCL/MYC expression. Hsa-miR-150p is nodular-specifically overexpressed, and its target ZEB1 was significantly downregulated in nodular SGC suggesting a tumour suppressor role. Invasive pagetoid subtype demonstrated specific overexpression of hsa-miR-205 and downregulation of hsa-miR-199a. Correspondingly, miRNA gene targets, EZH2 (by hsa-miR-205) and CD44 (by hsa-miR-199a), were both overexpressed in pagetoid SGC. CD44 has been identified as a potential cancer stem cell marker in head and neck squamous cell carcinoma and its overexpression in pagetoid cells represents a novel treatment target. Aberrant miRNAs and their gene targets have been identified in both SGC subtypes, paving the way for better molecular understanding of these tumours and identifying new treatment targets. |
format |
article |
author |
John C. Bladen Jun Wang Ajanthah Sangaralingam Mariya Moosajee Caroline Fitchett Claude Chelala Michele Beaconsfield Edel A. O’Toole Michael P. Philpott Daniel G. Ezra |
author_facet |
John C. Bladen Jun Wang Ajanthah Sangaralingam Mariya Moosajee Caroline Fitchett Claude Chelala Michele Beaconsfield Edel A. O’Toole Michael P. Philpott Daniel G. Ezra |
author_sort |
John C. Bladen |
title |
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma |
title_short |
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma |
title_full |
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma |
title_fullStr |
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma |
title_full_unstemmed |
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma |
title_sort |
microrna and transcriptome analysis in periocular sebaceous gland carcinoma |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/a8dbd7b7e4544abea6e78840cdc42587 |
work_keys_str_mv |
AT johncbladen micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT junwang micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT ajanthahsangaralingam micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT mariyamoosajee micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT carolinefitchett micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT claudechelala micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT michelebeaconsfield micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT edelaotoole micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT michaelpphilpott micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma AT danielgezra micrornaandtranscriptomeanalysisinperiocularsebaceousglandcarcinoma |
_version_ |
1718384677092327424 |